Conclusions and Policy Suggestions

Mainak Mazumdar ()
Additional contact information
Mainak Mazumdar: Centre De Sciences Humaines (CSH)

Chapter Chapter 8 in Performance of Pharmaceutical Companies in India, 2013, pp 169-179 from Springer

Abstract: Abstract The Indian pharmaceutical industry is at the crossroads due to the recognition of the product patent in the amended Patent Act of 2005 and the gradual liberalization policy of the government of India. While the recognition of product patents is a big challenge for Indian pharmaceutical companies that have hitherto relied on imitation for their growth, the liberalization of the market economy has also opened up new opportunities for Indian pharmaceutical firms. In response to policy changes and growing competition, firms started adopting new strategies like increased outlays in R&D related activities, endeavors to sell their product in the global market and investment in plant and machinery. However, the benefit from such change may not be immediate. Also, when access to resources and technology differs across firms, the process of liberalization may create winners and losers and performance differences may widen between firms.

Keywords: Technical Change; Efficiency Score; Production Frontier; Malmquist Productivity Index; Bulk Drug (search for similar items in EconPapers)
Date: 2013
References: Add references at CitEc
Citations:

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:conchp:978-3-7908-2876-4_8

Ordering information: This item can be ordered from
http://www.springer.com/9783790828764

DOI: 10.1007/978-3-7908-2876-4_8

Access Statistics for this chapter

More chapters in Contributions to Economics from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().